Organization | Saint Francis Hospital and Medical Center

Saint Francis Hospital and Medical Center Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Hartford CT United States (1897)

Organization Overview

First Clinical Trial

2008

NCT00773786

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Saint Francis Care | Saint Francis Hospital and Medical Center | St. Francis Hospital - The Heart Center

Active Ingredients

Drugs in Phase 4 Trials (2)

arformoterol (brovana) (1 trial)

zinc sulfate (1 trial)

Drugs in Phase 2 Trials (3)

COVID-19 convalescent plasma (1 trial)

thiamine (1 trial)

vitamin c (1 trial)

Drugs in Other Trials (6)

acetaminophen (tylenol) (1 trial)

bupivacaine (Exparel) (1 trial)

epinephrine (levophed) (1 trial)

interferon beta-1b (betaseron) (1 trial)

levobupivacaine (chirocaine) (1 trial)

ropivacaine (naropin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronavirus Infections (Phase 4)

Sepsis (Phase 2)

Severe Acute Respiratory Syndrome (Phase 4)

Shock, Septic (Phase 2)

Toxemia (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 11